ASHM’s Taskforce on BBVs, Sexual Health and COVID-19 presents a lunchtime webinar - The Indigenous Health Response… https://t.co/bM2BFg81Rx
Presenter: Professor Donna Mak
Given my own interest in gonorrhoea, it has been fascinating hearing what is happening in other parts of the country.
Here, Professor Mak presented the WA epidemiological data.
She noted that whilst rates remained highest in the historically high incidence ATSI group; these rates were relatively static. The highest rate of rise of incidence was observed in heterosexual urban females. The age group of highest incidence has shifted from the younger 15-24 age group to the 25-34yo age group.
They have an enviable program which allows them to assess the proportion of positive tests with the denominator of all requested pathology (apart from a single laboratory) and noted that the percent of positive tests are rising.
From 1st July 2017, enhanced surveillance for gonorrhoea has been implemented in WA; which involves a fax to the test provider with treatment recommendations and contact tracing recommendations plus some data collection. If there’s no response, in certain groups follow up will be implemented: that is if the patient is under 16, tested by corrective services, ATSI, pregnant, a sex worker or client, outside Metro Perth, homeless or tested in hospital or by an after hours GP.
Strains circulating in ATSI populations seem to remain sensitive to triple ‘zap packs’ of amoxicillin, azithromycin and probenecid; whilst urban populations are being treated in line with dual therapy recommendations.